CREATE Medicines Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
CREATE Medicines is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on in vivo programming of immune responses across multiple pathways. It operates a proprietary platform that delivers mRNA-based instructions to immune cells inside the body, enabling scalable, repeat-dose, off-the-shelf immunotherapies. This approach underpins a pipeline of in vivo CAR therapies aimed at improving outcomes in cancer, autoimmune diseases, and fibrosis. The company concentrates on oncology while autoimmune programs remain in preclinical testing. Recent updates highlight MT-302 as a candidate for TROP2-expressing cancers, including potential first-line use in gastroesophageal junction carcinoma.